Dong-A Socio Holdings Co. Ltd. (000640) - Financial and Strategic SWOT Analysis Review

  • ID: 2894249
  • SWOT Analysis
  • 40 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • BIOCND Inc.
  • Daewoong Bio, Inc.
  • Oscotec Inc.
  • MORE
Dong-A Socio Holdings Co. Ltd. (000640) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Dong-A Socio Holdings Co., Ltd. (Dong-A Socio Holdings), formerly Dong-A Pharmaceutical Co., Ltd., is a holding company. It operates in various markets such as pharmaceuticals, food and beverages, logistics, IT, and materials through its subsidiaries. The group focuses on new business investments, development of biomedicines and research and development of new innovative drugs. Its main business areas include the manufacture of over-the-counter (OTC) and ethical drugs (ETC). The group’s subsidiary, Dong-A Pharmaceutical, manufactures OTC drugs, quasi-drugs such as Bacchus and health functional products. Its major products include Panpyrin-T, Panpyrin Q, Morning Care, Bacchus, Garglin and Tempo, among others. Another subsidiary, Dong-A ST, manufactures ethical drugs, medical equipment and diagnostics. Its major products include Eporon, Growtropin, Leucostim and Stillen, among others. It is a subsidiary of Dong-A Socio Group. Dong-A Socio Holdings is headquartered in Seoul, Korea.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • BIOCND Inc.
  • Daewoong Bio, Inc.
  • Oscotec Inc.
  • MORE
List of Tables

List of Figures

Section 1 - About the Company

Dong-A Socio Holdings Co. Ltd. - Key Facts

Dong-A Socio Holdings Co. Ltd. - Key Employees

Dong-A Socio Holdings Co. Ltd. - Major Products and Services

Dong-A Socio Holdings Co. Ltd. - Pharmaceutical Pipeline Products Data

Dong-A Socio Holdings Co. Ltd., Pipeline Products by Therapy Area

Dong-A Socio Holdings Co. Ltd., Pipeline Products by Development Phase

Dong-A Socio Holdings Co. Ltd. - History

Dong-A Socio Holdings Co. Ltd. - Company Statement

Dong-A Socio Holdings Co. Ltd. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Dong-A Socio Holdings Co. Ltd. - Business Description

Dong-A Socio Holdings Co. Ltd. - Corporate Strategy

Dong-A Socio Holdings Co. Ltd. - SWOT Analysis

SWOT Analysis - Overview

Dong-A Socio Holdings Co. Ltd. - Strengths

Dong-A Socio Holdings Co. Ltd. - Weaknesses

Dong-A Socio Holdings Co. Ltd. - Opportunities

Dong-A Socio Holdings Co. Ltd. - Threats

Dong-A Socio Holdings Co. Ltd. - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Dong-A Socio Holdings Co. Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Dong-A Socio Holdings Co. Ltd., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Dong-A Socio Holdings Co. Ltd., Recent Deals Summary

Section 5 – Appendix

Methodology

Ratio Definitions

About us

Contact Us

Disclaimer

List of Tables

Dong-A Socio Holdings Co. Ltd., Key Facts

Dong-A Socio Holdings Co. Ltd., Key Employees

Dong-A Socio Holdings Co. Ltd., Major Products and Services

Dong-A Socio Holdings Co. Ltd., Number of Pipeline Products by Therapy Area

Dong-A Socio Holdings Co. Ltd., Number of Pipeline Products by Development Stage

Dong-A Socio Holdings Co. Ltd., Pipeline Products By Therapy Area and Development Phase

Dong-A Socio Holdings Co. Ltd., History

Dong-A Socio Holdings Co. Ltd., Subsidiaries

Dong-A Socio Holdings Co. Ltd., Key Competitors

Dong-A Socio Holdings Co. Ltd., Ratios based on current share price

Dong-A Socio Holdings Co. Ltd., Annual Ratios

Dong-A Socio Holdings Co. Ltd., Interim Ratios

Dong-A Socio Holdings Co. Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Dong-A Socio Holdings Co. Ltd., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Dong-A Socio Holdings Co. Ltd., Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

Dong-A Socio Holdings Co. Ltd., Pipeline Products by Therapy Area

Dong-A Socio Holdings Co. Ltd., Pipeline Products by Development Phase

Dong-A Socio Holdings Co. Ltd., Performance Chart (2011 - 2015)

Dong-A Socio Holdings Co. Ltd., Ratio Charts

Dong-A Socio Holdings Co. Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Dong-A Socio Holdings Co. Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
SeouLin Bioscience Co., Ltd.
Oscotec Inc.
J Communications Co., Ltd. (Inactive)
Daewoong Bio, Inc.
BIOCND Inc.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll